Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
Clinical trial NCT05646576 · RECRUITING
Trial details
- NCT number
- NCT05646576
- Sponsor
- Massachusetts General Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-30
- Primary completion
- 2026-12-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.